Equities

Aoxing Pharmaceutical Company Inc

AOXG:PKC

Aoxing Pharmaceutical Company Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.0094
  • Today's Change0.00 / 0.00%
  • Shares traded20.00k
  • 1 Year change+754.55%
  • Beta--
Data delayed at least 15 minutes, as of Sep 17 2024 19:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Jun 30 2016201620152014
ASSETS
Cash And Short Term Investments6.915.372.33
Total Receivables, Net115.853.89
Total Inventory2.843.242.20
Prepaid expenses5.916.632.51
Other current assets, total------
Total current assets272111
Property, plant & equipment, net262926
Goodwill, net------
Intangibles, net1.880.480.55
Long term investments0.000.100.19
Note receivable - long term------
Other long term assets----0
Total assets565338
LIABILITIES
Accounts payable2.713.873.88
Accrued expenses9.636.024.43
Notes payable/short-term debt111411
Current portion long-term debt/capital leases141614
Other current liabilities, total--0.91--
Total current liabilities384134
Total long term debt01.377.50
Total debt253233
Deferred income tax------
Minority interest(1.06)(1.18)(1.5)
Other liabilities, total0.340.370.37
Total liabilities374241
SHAREHOLDERS EQUITY
Common stock0.080.070.05
Additional paid-in capital746658
Retained earnings (accumulated deficit)(56)(58)(64)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total1.723.072.98
Total equity1911(2.51)
Total liabilities & shareholders' equity565338
Total common shares outstanding767050
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.